The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
出版年份 2022 全文链接
标题
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodies
作者
关键词
-
出版物
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 119, Issue 21, Pages -
出版商
Proceedings of the National Academy of Sciences
发表日期
2022-05-17
DOI
10.1073/pnas.2200413119
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Type I interferons and SARS-CoV-2: from cells to organisms
- (2022) Paul Bastard et al. CURRENT OPINION IN IMMUNOLOGY
- Inherited IFNAR1 Deficiency in a Child with Both Critical COVID-19 Pneumonia and Multisystem Inflammatory Syndrome
- (2022) Hassan Abolhassani et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Human genetic and immunological determinants of critical COVID-19 pneumonia
- (2022) Qian Zhang et al. NATURE
- Why do people die from COVID-19?
- (2022) Paul Bastard SCIENCE
- COVID-19 convalescent plasma composition and immunological effects in severe patients
- (2021) Yeny Acosta-Ampudia et al. JOURNAL OF AUTOIMMUNITY
- Immune determinants of COVID-19 disease presentation and severity
- (2021) Petter Brodin NATURE MEDICINE
- COVID-19 and the human innate immune system
- (2021) Joachim L. Schultze et al. CELL
- Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine
- (2021) Paul Bastard et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Autoantibodies against type I interferons are associated with multi-organ failure in COVID-19 patients
- (2021) Rutger Koning et al. INTENSIVE CARE MEDICINE
- Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma
- (2021) Sara E. Vazquez et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Neutralizing Autoantibodies to Type I IFNs in >10% of Patients with Severe COVID-19 Pneumonia Hospitalized in Madrid, Spain
- (2021) Jesús Troya et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Interferon-β Therapy in a Patient with Incontinentia Pigmenti and Autoantibodies against Type I IFNs Infected with SARS-CoV-2
- (2021) Paul Bastard et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1
- (2021) Paul Bastard et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Diverse Functional Autoantibodies in Patients with COVID-19
- (2021) Eric Y. Wang et al. NATURE
- Natural mucosal barriers and COVID-19 in children
- (2021) Carl A. Pierce et al. JCI Insight
- Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19
- (2021) Carly G.K. Ziegler et al. CELL
- The interferon landscape along the respiratory tract impacts the severity of COVID-19
- (2021) Benedetta Sposito et al. CELL
- Neutralizing type‐I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID‐19
- (2021) Michael S Abers et al. IMMUNOLOGY AND CELL BIOLOGY
- Harnessing Type I IFN Immunity Against SARS-CoV-2 with Early Administration of IFN-β
- (2021) Donald C. Vinh et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs
- (2021) Jonathan Lopez et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19
- (2021) Monique G. P. van der Wijst et al. Science Translational Medicine
- New-onset IgG autoantibodies in hospitalized patients with COVID-19
- (2021) Sarah Esther Chang et al. Nature Communications
- TBK1 and TNFRSF13B mutations and an autoinflammatory disease in a child with lethal COVID-19
- (2021) Axel Schmidt et al. npj Genomic Medicine
- Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths
- (2021) Paul Bastard et al. Science Immunology
- X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19
- (2021) Takaki Asano et al. Science Immunology
- Temporal Dynamics of Anti-Type 1 Interferon Autoantibodies in COVID-19 Patients
- (2021) Elana R Shaw et al. CLINICAL INFECTIOUS DISEASES
- Interferon-α2 Auto-antibodies in Convalescent Plasma Therapy for COVID-19
- (2021) Matthijs P. Raadsen et al. JOURNAL OF CLINICAL IMMUNOLOGY
- A Case of Autosomal Recessive Interferon Alpha/Beta Receptor Alpha Chain (IFNAR1) Deficiency with Severe COVID-19
- (2021) Shaghayegh Khanmohammadi et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Pre-existing Autoantibodies Neutralizing High Concentrations of Type I Interferons in Almost 10% of COVID-19 Patients Admitted to Intensive Care in Barcelona
- (2021) Xavier Solanich et al. JOURNAL OF CLINICAL IMMUNOLOGY
- X-Linked TLR7 Deficiency Underlies Critical COVID-19 Pneumonia in a Male Patient with Ataxia-Telangiectasia
- (2021) Hassan Abolhassani et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Mechanisms of viral inflammation and disease in humans
- (2021) Jean-Laurent Casanova et al. SCIENCE
- Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort
- (2021) Raphael Carapito et al. Science Translational Medicine
- Microarray-Based Detection of Antibodies against SARS-CoV-2 Proteins, Common Respiratory Viruses and Type I Interferons
- (2021) Elena Savvateeva et al. Viruses-Basel
- Lethal Infectious Diseases as Inborn Errors of Immunity: Toward a Synthesis of the Germ and Genetic Theories
- (2020) Jean-Laurent Casanova et al. Annual Review of Pathology-Mechanisms of Disease
- Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19
- (2020) Daniel Blanco-Melo et al. CELL
- A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 Infection
- (2020) Jean-Laurent Casanova et al. CELL
- Autoantibodies against cytokines: phenocopies of primary immunodeficiencies?
- (2020) Chen-Lung Ku et al. HUMAN GENETICS
- Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling
- (2020) Benjamin Israelow et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Quantification and interpretation of attributable mortality in core clinical infectious disease journals
- (2020) Maja von Cube et al. LANCET INFECTIOUS DISEASES
- Characteristics of SARS-CoV-2 and COVID-19
- (2020) Ben Hu et al. NATURE REVIEWS MICROBIOLOGY
- Inborn errors of type I IFN immunity in patients with life-threatening COVID-19
- (2020) Qian Zhang et al. SCIENCE
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- Genetic Lesions of Type I Interferon Signalling in Human Antiviral Immunity
- (2020) Christopher J.A. Duncan et al. TRENDS IN GENETICS
- Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications
- (2020) Andrew T. Levin et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Untuned antiviral immunity in COVID-19 revealed by temporal type I/III interferon patterns and flu comparison
- (2020) Ioanna-Evdokia Galani et al. NATURE IMMUNOLOGY
- REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
- (2020) David M. Weinreich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial
- (2020) Phillip D Monk et al. Lancet Respiratory Medicine
- Plasmacytoid dendritic cell and myeloid dendritic cell function in ageing: A comparison between elderly and young adult women
- (2019) Marloes van Splunter et al. PLoS One
- Blockade of Interferon Beta, but Not Interferon Alpha, Signaling Controls Persistent Viral Infection
- (2015) Cherie T. Ng et al. Cell Host & Microbe
- Nocardia-Induced Granulocyte Macrophage Colony-Stimulating Factor Is Neutralized by Autoantibodies in Disseminated/Extrapulmonary Nocardiosis
- (2014) Lindsey B. Rosen et al. CLINICAL INFECTIOUS DISEASES
- The JAK-STAT Pathway at Twenty
- (2012) George R. Stark et al. IMMUNITY
- Evolutionary genetic dissection of human interferons
- (2011) Jérémy Manry et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I
- (2010) Anne Puel et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines
- (2010) Kai Kisand et al. JOURNAL OF EXPERIMENTAL MEDICINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started